EcoDrugPlus

Neurotensin Receptor 1

Ensembl ID : ENSBSLG00000022248
Gene Symbol: NTSR1
3 Cross references
199 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 1

Ensembl ID : ENSBSLG00000014067
Gene Symbol: NTRK1
3 Cross references
200 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSBSLG00000003726
Gene Symbol: NTRK2
3 Cross references
208 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSBSLG00000000671
Gene Symbol: NTRK3
3 Cross references
183 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSBSLG00000021924
Gene Symbol: NTRK3
3 Cross references
203 Possible Orthologues:

Nicastrin

Ensembl ID : ENSBSLG00000022614
Gene Symbol: NCSTN
1 Cross references
203 Possible Orthologues:

Nicastrin

Ensembl ID : ENSBSLG00000022585
Gene Symbol: NCSTN
3 Cross references
203 Possible Orthologues:

Nicotinamide Phosphoribosyltransferase

Ensembl ID : ENSBSLG00000015932
Gene Symbol: NAMPT
3 Cross references
219 Possible Orthologues:

Nischarin

Ensembl ID : ENSBSLG00000003196
Gene Symbol: NISCH
3 Cross references
210 Possible Orthologues:

Notch Receptor 1

Ensembl ID : ENSBSLG00000014799
Gene Symbol: NOTCH1
3 Cross references
200 Possible Orthologues:

Nuclear Factor Kappa B Subunit 1

Ensembl ID : ENSBSLG00000003947
Gene Symbol: NFKB1
3 Cross references
202 Possible Orthologues:

Nuclear Factor, Erythroid 2 Like 2

Ensembl ID : ENSBSLG00000026266
Gene Symbol: NFE2L2
3 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).